By Chris Hutching
|
Friday 27th October 2000 |
Text too small? |
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
POT completes sale of Rolleston property asset
RAD - Radius Health to Release 1H27 Results on 11 November 2026
PCT Climate Related Disclosures 2026
SPN confirms FY26 result & provides leadership update
AGL - Accordant Group FY27 Half Year results
AIR - Air NZ to hold investor update
NZM - NZME receives offer for renewal of radio spectrum licences
October 28th Morning Report
ARG - FY27 interim results announcement date and webcast details
Devon Funds Morning Note - 27 October 2026